Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only

BACKGROUND: The prognosis of metastatic colorectal cancer (mCRC) depends on the metastatic site and systemic therapy regimen. Peritoneal metastases are associated with a relatively unfavorable prognosis among patients with mCRC. In this article, we present the treatment outcomes of patients with per...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ching-Chun, Chang, Tsung-Kun, Chen, Yen-Cheng, Tsai, Hsiang-Lin, Huang, Ching-Wen, Su, Wei-Chih, Ma, Cheng-Jen, Yin, Tzu-Chieh, Chen, Po-Jung, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045595/
https://www.ncbi.nlm.nih.gov/pubmed/35498511
http://dx.doi.org/10.2147/CMAR.S355318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045595/
https://www.ncbi.nlm.nih.gov/pubmed/35498511
http://dx.doi.org/10.2147/CMAR.S355318

Ejemplares similares